Conagra Brands has cleared its Q4 earnings hurdle, but the week after the print tells a more complicated story: short sellers have rebuilt positions while the stock sits barely above the mean analyst price target at $14.15.
The clearest post-earnings signal is a renewed increase in bearish positioning. Short interest climbed 6.2% on the week to 11.3% of the free float — reversing the pre-earnings trim noted in the previous note. That monthly acceleration is steeper still: short interest has grown 15.5% over the past 30 days. The lending market is not the constraint here. Availability has eased somewhat from last week's 654%, but at 574%, there are still more than five shares available to borrow for every share already lent out — plenty of room for shorts to press further. Cost to borrow has ticked up 34% on the week to 0.46%, which sounds dramatic but remains trivially low in absolute terms. Shorts face no squeeze pressure from the borrow market whatsoever. Options positioning is equally calm: the put/call ratio of 0.55 is almost exactly at its 20-day average, with a z-score near zero — options traders are not adding directional conviction in either direction after the print.
The Street is similarly non-committal, though the overall tone remains cautious. Barclays was the most notable recent mover, trimming its target from $18 to $16 on July 8 while keeping an Overweight rating — a signal that even the bulls are shaving their numbers. The broader analyst community has been uniformly cutting targets since early June, with Morgan Stanley, JP Morgan, Deutsche Bank, RBC Capital, UBS, and Bernstein all reducing estimates last month. The mean target now sits at $14.32, just $0.17 above the current price — a razor-thin buffer that leaves effectively priced at consensus fair value. Bears highlight forward EPS momentum ranking in just the 10th percentile of the universe over the past 30 days. Bulls point to a 12-month forward EPS estimate that ranks in the 96th percentile on year-over-year improvement — a sharp contrast that reflects genuine disagreement about the trajectory rather than a clear directional read. EV/EBITDA of 8.6x has drifted higher over the past month, which is the wrong direction for a stock trying to attract new buyers on valuation grounds.
The peer group fared poorly this week, which limits the read on CAG's own relative performance. GIS fell 1.7% on the week, CPB dropped 3.5%, and POST lost 4.1%. Against that backdrop, CAG's 0.9% weekly gain is a marginal outperformance — though it followed a stronger week before earnings. The institutional picture is notable: BlackRock added 28 million shares as of June 30, lifting its stake to 13.5% of shares outstanding. That is a material addition from a passive and active manager of that scale, and it provides a degree of structural support in the register.
The insider angle from April — the Chairman buying $358k and a director buying $250k at around $14.30 — now reads as an accurate near-term call on the floor, though the stock has not meaningfully moved from that level since. Both buys were placed within a few cents of where CAG trades today, suggesting the floor has held but the catalyst for a break higher has not yet materialised. The short score has been edging up all week, reaching 53.6 — its highest reading of the past ten days — as the post-earnings short rebuild registers in the composite signal.
What to watch next is whether the rebuilt short position holds or continues to grow now that the earnings event has passed and traders must take a view on FY27 guidance delivery — specifically whether volume trends in frozen and snacks can stabilise enough to give the analyst community a reason to stop trimming targets.
See the live data behind this article on ORTEX.
Open CAG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
